Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Subspecialties: Page 1109
Lawsuit hits Canadian cancer center for radiation therapy errors
By
Cynthia E. Keen
A Canadian cancer center has been hit with a class action lawsuit claiming that hundreds of patients received improper levels of radiation during radiation therapy treatments over a three-year period.
December 29, 2008
Pediatric Hodgkin's survivors face high risk of breast cancer as young adults
By
Cynthia E. Keen
Girls who received treatment for Hodgkin's disease between 1960 and 1990 and are now adult women have a 37-fold increased risk of developing breast cancer compared to the general population. The U.S. study also found that these patients had a high likelihood of developing bilateral breast cancer at an early age.
December 29, 2008
Isotropic 3T MRI aids in diagnosing labrum, rotator cuff tears
By
Wayne Forrest
Isotropic MR imaging of the shoulder with multiplanar reconstruction is a useful method in diagnosing labrum and rotator cuff tears, especially for anterior labral tears related to anterior instability, according to Korean researchers.
December 28, 2008
3D image guidance improves spinal surgery outcomes
By
Erik L. Ridley
3D image guidance can successfully be used to place thoracolumbar pedicle screws, yielding fewer misplaced screws and avoiding radiation exposure from fluoroscopy, according to an article published online in the
Journal of Neurosurgery: Spine
.
December 28, 2008
Adding CsI-based dual-energy imaging doesn't improve lung nodule detection
By
Radiology Review
(Radiology Review) New research suggests that cesium iodide (CsI) detector-based dual-exposure dual-energy imaging, when added to chest radiography, does not significantly improve the detection or classification of pulmonary nodules.
December 25, 2008
Greatest pain comes four hours after MR arthrogram injection
By
Wayne Forrest
Researchers in Switzerland have found that patients who undergo MR arthrography temporarily experience the most pain in the affected joints four hours after injection. The study also showed that the pain is most pronounced in younger patients, but the discomfort for virtually all patients disappears after one week.
December 25, 2008
Multislice CT beats aortography for pediatric thoracic aortic coarctation
By
Caitanya Min
Results from a study by Tunisian researchers indicate that compared with invasive contrast aortography, 64-slice CT is the imaging modality of choice for pediatric patients with thoracic aortic coarctation.
December 24, 2008
Ultrasound suitable for soft-tissue mass triage
By
Erik L. Ridley
Ultrasound can be a useful triage tool for evaluating soft-tissue masses, according to researchers from Leeds Teaching Hospitals NHS Trust in the U.K. They prospectively studied 358 consecutive patients with soft-tissue masses who had received ultrasound exams over a six-month period.
December 23, 2008
Sleep cuts coronary artery calcification
By
Eric Barnes
It is sleep, wrote William Shakespeare, that "knits up the ravelled sleave of care." But maybe just as important, a new study shows that getting enough sleep prevents coronary artery calcifications, which are strongly associated with morbidity and mortality.
December 22, 2008
Molecular Insight completes phase II trial for Zemiva
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals has completed a phase II clinical trial for its chest imaging agent Zemiva.
December 22, 2008
AAPM approves Image Gently work group agenda
By
AuntMinnie.com staff writers
The Image Gently Pediatric CT Physics Work Group has received formal consensus approval from the American Association of Physicists in Medicine (AAPM) to proceed with its work to establish consistency among CT scanner equipment measuring pediatric radiation dose.
December 22, 2008
Epix gets FDA OK for Vasovist
By
AuntMinnie.com staff writers
MRI contrast developer Epix Pharmaceuticals has received approval from the U.S. Food and Drug Administration to market its blood pool MR angiography contrast agent.
December 22, 2008
Previous Page
Page 1109 of 1583
Next Page